neuroprotection by the maintenance of blood brain barrier
Project/Area Number |
26462334
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Anesthesiology
|
Research Institution | Gifu University |
Principal Investigator |
Tanabe Kumiko 岐阜大学, 大学院医学系研究科, 准教授 (30402209)
|
Co-Investigator(Kenkyū-buntansha) |
小澤 修 岐阜大学, 大学院医学系研究科, 教授 (90225417)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 中枢神経保護 / サイトカイン / 細胞内情報伝達 / IL-1β / IL-6 / cAMP / STAT3 / interleukin-1β / interleukin-6 / グリア細胞 |
Outline of Final Research Achievements |
It has been reported that interleukin (IL)-1β induces IL-6 synthesis in rat glioma cell line, C6 cells and that cAMP enhances IL-1β-induced IL-6 synthesis. We investigated the details behind enhancement of IL-1β-induced IL-6synthesis by cAMP. In conclusion, adenylyl cyclase/cAMP/PKA pathway upregulates IL-1β-induced IL-6 synthesis through enhancement of the JAK2/STAT3 pathway. In addition, dexmedetomidine, intravenous anesthetic agent, inhibits IL-1β-induced IL-6 synthesis independently of the adenylyl cyclase/cAMP pathway through its receptor (α2 adrenoceptor).
|
Report
(4 results)
Research Products
(10 results)
-
-
[Journal Article] Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase.2015
Author(s)
Iida Y, Doi T, Tokuda H, Matsushima-Nishiwaki R, Tsujimoto M, Kuroyanagi G, Yamamoto N, Enomoto Y, Tanabe K, Otsuka T, Iwama T, Ogura S, Kozawa O, Iida H.
-
Journal Title
Prostaglandins Leukot Essent Fatty Acids.
Volume: 94
Pages: 73-81
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-
-
-